Answer
Ultomiris (ravulizumab) has no or negligible influence on the ability to drive and use machines.
Sources for this answer
- Ultomiris 300 mg/3 mL and 1100 mg/11 mL PLGB 31187/0007Alexion Pharma UK Ltd · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 11Document updated
Sources checked